1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

GenVec, Inc. Investor Investigation announced by Shareholders Foundation

An investigation for shareholders of GenVec, Inc. (NASDAQ:GNVC) over possible securities laws violations was announced and NASDAQ: GNVC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

FOR IMMEDIATE RELEASE

 
 
mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
PRLog (Press Release) - Jan. 24, 2012 - The Shareholders Foundation announces that an investigation on behalf of investors in shares of GenVec, Inc. (NASDAQ:GNVC) over potential securities laws violations by certain officers and directors at GenVec was announced.

If you purchased shares of GenVec, Inc. (NASDAQ: GNVC), you may have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of GenVec, Inc. (NASDAQ:GNVC) concerning whether the company, certain of its officers and directors, or others have possibly violated federal securities laws. Specifically, the investigation concerns whether certain statements GenVec’s business, its prospects and its operations were potentially materially false and misleading at the time they were made.

On  March 29, 2010, GenVec, Inc. (Nasdaq: GNVC) announced that it is discontinuing its Phase 3 clinical trial of TNFerade(TM) in patients with locally advanced pancreatic cancer based on results of an interim analysis.  GenVec, Inc said that this interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.

GenVec said that it has determined, after conferring with its independent Data Safety Monitoring Board, that the PACT trial would not meet the goal of demonstrating persuasive evidence of clinical effectiveness that could form the basis for regulatory approval in the population chosen for study.

For more information go to www.ShareholdersFoundation.com or contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

# # #

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Photo:
http://www.prlog.org/11779887/1

--- End ---

Click to Share

Contact Email:
***@shareholdersfoundation.com Email Verified
Source:Shareholders Foundation, Inc.
Phone:+1-(858)-779-1554
Fax:+1-(858)-605-5739
Address:3111 Camino Del Rio North - Suite 423
Zip:92108
City/Town:San Dimas
State/Province:California
Country:United States
Industry:Banking, Business, Finance
Tags:, NASDAQ:GNVC, , GenVec Inc, , , ,
Shortcut:http://prlog.org/11779887
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
8.4K1.9K2.6K
Click to Share